Zady Readymix Oral Suspension contains Azithromycin 100 mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, including community-acquired pneumonia, acute bacterial sinusitis, pharyngitis, and tonsillitis caused by susceptible strains of bacteria. Additionally, it is used for skin and soft tissue infections, as well as uncomplicated genital infections such as urethritis and cervicitis. Azithromycin acts by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thereby preventing bacterial growth and replication. The ready-to-use oral suspension formulation ensures ease of administration and accurate dosing, particularly in pediatric and geriatric populations. Zady Readymix is generally well tolerated; however, common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It is contraindicated in patients with known hypersensitivity to azithromycin, erythromycin, or any macrolide antibiotics. Caution is advised in patients with hepatic impairment or a history of QT prolongation. Dosage and duration of therapy should be based on the severity of infection and patient-specific factors. Proper adherence to prescribed regimens is essential to prevent the development of antibiotic resistance.